https://www.selleckchem.com/pr....oducts/dansylcadaver
1 preop to 57.2 at one month and 49.7 at five months). Peripheral nerve stimulator implantation may be a promising intervention when other analgesic modalities fail to manage refractory GFN. Further research to verify the effectiveness of this intervention and evaluate for appropriate integration in patient care is required. Peripheral nerve stimulator implantation may be a promising intervention when other analgesic modalities fail to manage refractory GFN. Further research to verify the effectiveness of
Curtir
Comentario
Compartilhar
